News
Academy
Publications
All Publications
E-Books
Media
Editorial Podcasts
Editorial Videos
Peer Exchange
Practice Academy
Shorts
Sponsored Podcasts
Sponsored Videos
More
Conferences
Conference Coverage
Conference Listing
Columns
All Columns
A Closing Thought
Clinical Trial Insights
View from Brussels
View from Washington
Resources
Advertise
Blogs
Events
Front & Center
Partner Perspectives
White Papers
Events
Webcasts
Event Calendar
Subscribe
My Account
News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar
Clinical Operations & Strategy
Decentralized Clinical Trials
Trial Design
Investigative Sites
CRO/Sponsor
Risk-Based Monitoring
Protocol Design
Clinical Trial Supply Chain
Study Start-Up
Early Phase Development
DEI
Industry Initiatives
Diversity Action Plans
Recruitment
Data Management
Analytics
Electronic Data Capture
Real World Evidence
Metrics & Benchmarks
Patient Participation
Integrated Research
CRAACO
Enrollment
Regulatory
Institutional Review Board & Ethics Committee
FDA
EMA
Technology
Artificial Intelligence/Machine Learning
eClinical
mHealth
Choose Specialty
Spotlight -
Conference Coverage
|
Peer Exchange
|
DE&I
|
Editorial Videos
|
Clinical Operations & Strategy
|
Patient Participation
Advertisement
Maureen Lyden
Advertisement
Articles by Maureen Lyden
Diabetes Research in Clinical Trials
By
Maureen Lyden
November 8th 2012
Applied Clinical Trials
Biostatisicians Can Improve Trial Design
By
Maureen Lyden
September 27th 2012
Applied Clinical Trials
Advertisement
Latest Updated Articles
Biostatisicians Can Improve Trial Design
September 27th 2012
Diabetes Research in Clinical Trials
November 8th 2012
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
5
What a Lean Development Model Actually Means for Biotech Operations Today